TEMI

Does Medicaid Cover Ozempic? Coverage Rules by State and Plan

15 min read

Share

Does Medicaid Cover Ozempic? Coverage Rules by State and Plan

Written by Temi Editorial

TL;DR

Medicaid may cover Ozempic for type 2 diabetes. It may deny Ozempic when prescribed only for weight loss because Ozempic is not FDA-approved for that use. Coverage depends on the diagnosis, state policy, managed-care plan, formulary, and prior authorization records.

Does Medicaid cover Ozempic? The short answer

Does Medicaid cover Ozempic? The short answer

Medicaid may cover Ozempic for type 2 diabetes. It may deny the same drug when prescribed only for weight loss. Ozempic is not FDA-approved for weight loss.

A prescription does not create coverage. The diagnosis, state rules, plan formulary, and prior authorization criteria control the claim.

Last reviewed: September 2026. Formularies can change before this page is updated. We recommend confirming the rule for the exact plan and fill date.

Ozempic for type 2 diabetes

A Medicaid plan may require a confirmed type 2 diabetes diagnosis. It may also request chart notes, A1C results, current medicines, prior treatments, and the requested dose.

Other restrictions may apply:

  • Prior authorization
  • Step therapy
  • Preferred-drug rules
  • Quantity limits
  • Refill timing limits
  • Authorization renewal dates

For example, a claim may reject even when the patient has diabetes and an A1C record. The prescriber may need to submit the diagnosis, lab results, metformin history, and dose request.

Ozempic for weight loss

Prescribing Ozempic only for weight loss is off-label. A Medicaid plan may exclude that use even when it covers Ozempic for diabetes.

Check weight-management drugs separately. Do not assume that Ozempic coverage proves coverage for Wegovy or another GLP-1 drug. Patients reviewing treatment progress can also use our four-week semaglutide weight-loss audit before discussing dose, adherence, or treatment changes with a prescriber.

Medicaid GLP-1 coverage by state and plan

Simple state labels can mislead. Each claim may pass through four layers: state policy, the fee-for-service drug list, a managed-care formulary, and patient-specific authorization rules.

The table below is a verification index for all 50 states and Washington, DC. “Unconfirmed” means the source material did not provide a current primary formulary rule. Use the official Medicaid state contact directory to find the current state source.

StateDrug and indicationPA statusFee-for-service ruleManaged-care variationPrimary source statusLast checked
AlabamaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
AlaskaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specific if applicableState confirmation neededSep. 2026
ArizonaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
ArkansasOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
CaliforniaOzempic—T2D; weight drugs separateUnconfirmedCheck current drug listPlan and benefit-specificState confirmation neededSep. 2026
ColoradoOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
ConnecticutOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLProgram-specificState confirmation neededSep. 2026
DelawareOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
District of ColumbiaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificDistrict confirmation neededSep. 2026
FloridaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
GeorgiaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
HawaiiOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
IdahoOzempic—T2D reported covered; Wegovy weight loss reported excludedCheck criteriaCurrent PDL controlsPlan-specificPrimary rule not independently confirmedSep. 2026
IllinoisOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
IndianaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
IowaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
KansasOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
KentuckyOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
LouisianaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
MaineOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLProgram-specificState confirmation neededSep. 2026
MarylandOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
MassachusettsOzempic—T2D; weight drugs separateUnconfirmedCheck current drug listPlan-specificState confirmation neededSep. 2026
MichiganOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
MinnesotaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
MississippiOzempic—T2D reported covered; Wegovy reported limitedRequired for some usesCurrent PDL controlsPlan-specificPrimary rule not independently confirmedSep. 2026
MissouriOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
MontanaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specific if applicableState confirmation neededSep. 2026
NebraskaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
NevadaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
New HampshireOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
New JerseyOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
New MexicoOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
New YorkOzempic—T2D; weight drugs separateUnconfirmedCheck current drug listBenefit and plan-specificState confirmation neededSep. 2026
North CarolinaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
North DakotaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specific if applicableState confirmation neededSep. 2026
OhioOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
OklahomaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
OregonOzempic—T2D; weight drugs separateUnconfirmedCheck current drug listCoordinated-plan rules varyState confirmation neededSep. 2026
PennsylvaniaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
Rhode IslandOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
South CarolinaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
South DakotaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specific if applicableState confirmation neededSep. 2026
TennesseeOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
TexasOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
UtahOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
VermontOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLProgram-specificState confirmation neededSep. 2026
VirginiaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
WashingtonOzempic—T2D; weight drugs separateUnconfirmedCheck current drug listPlan-specificState confirmation neededSep. 2026
West VirginiaOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specificState confirmation neededSep. 2026
WisconsinOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLProgram-specificState confirmation neededSep. 2026
WyomingOzempic—T2D; weight drugs separateUnconfirmedCheck current PDLPlan-specific if applicableState confirmation neededSep. 2026

The source material reports diabetes coverage for Ozempic in Idaho and Mississippi. It reports different Wegovy weight-management rules in those states. That difference shows why one GLP-1 cannot stand in for another.

Every row should be checked against primary sources at least once every 90 days. A dated table remains a starting point, not a payment promise.

How to read the state coverage table

  • Covered: The formulary lists the drug for a covered use.
  • Prior authorization required: The plan must approve the request before payment.
  • Nonpreferred: The plan may require a preferred drug first.
  • Excluded: The benefit does not cover the drug or stated use.
  • Plan-specific: The member’s managed-care plan applies its own formulary or criteria within Medicaid rules.

The current member plan controls the pharmacy claim. Confirm the exact drug, strength, diagnosis, and fill date.

Why state policy may not match your plan

Managed-care organizations may use their own formularies. A state preferred drug list can include Ozempic while a managed-care plan treats it as nonpreferred.

Use the name on the current member ID card. Call the listed pharmacy benefit number, not an old state contact.

Fee-for-service Medicaid vs. Medicaid managed care

Fee-for-service Medicaid vs. Medicaid managed care

Fee-for-service Medicaid pays providers and pharmacies through the state program. Its state drug list and prior authorization rules usually control.

Medicaid managed care places the member in a health plan. That plan may maintain a separate formulary and use a pharmacy benefit manager to process claims.

The pharmacy benefit manager can explain claim processing and rejection codes. It is not always the final authority for an appeal. The plan handbook and denial notice state where an appeal must go.

Which formulary should you check?

Start with the plan name on the current Medicaid card. Then:

  1. Check the state preferred drug list.
  2. Check the managed-care formulary.
  3. Confirm the publication or effective date.
  4. Search for “Ozempic,” not only “semaglutide.”
  5. Confirm the prescribed strength and quantity.

The member portal, state Medicaid pharmacy page, plan formulary, and member handbook should provide these records.

What to do when two coverage sources conflict

Ask the plan which formulary applies on the planned fill date. Request the rule in writing or save the dated formulary page.

Then ask the pharmacy to submit the claim. Record the rejection code and full message. A claim result often identifies the next step more clearly than a general phone answer.

What Medicaid may require before it covers Ozempic

Prior authorization requires the prescriber to show that the request meets plan rules. Step therapy requires a patient to try a preferred treatment first unless an exception applies.

Plans may also impose preferred-drug rules, quantity limits, refill dates, and renewal deadlines. Criteria vary by state, plan, diagnosis, and date.

Diabetes requests may use A1C results, diagnosis records, and diabetes treatment history. Weight-management drug requests may use different records, such as BMI and weight-related conditions. Do not stop or change treatment without the prescriber.

Prior authorization records checklist

A complete request may include:

  • Diagnosis and matching diagnosis code
  • Recent chart notes
  • Relevant lab results, including A1C when requested
  • Current medicines
  • Past treatment dates and outcomes
  • Adverse effects
  • Contraindications or reasons a preferred drug is unsuitable
  • Requested dose and quantity
  • Treatment and monitoring plan

“Insufficient clinical information” often means the plan needs more records. The prescriber can resubmit the missing material within the stated deadline.

Step therapy, quantity limits, and renewals

A plan may require a preferred diabetes drug before Ozempic. A prescriber can request an exception when the preferred option is not appropriate, but the plan will usually require a clinical reason.

Dose changes can also cause quantity rejections. Check the authorization end date before the next refill. An approval from six months ago may no longer support the current claim.

How to verify Ozempic coverage before the pharmacy fills it

Use one ordered process:

  1. Search the member portal or current formulary.
  2. Call the plan’s pharmacy benefit line.
  3. Give the prescriber the required authorization criteria.
  4. Ask the pharmacy to submit a claim before pickup.
  5. Record the date, representative, reference number, and exact response.

A verbal answer is not a guarantee of payment. The submitted pharmacy claim determines whether the fill processes under the current information.

Questions to ask the Medicaid plan

Ask these questions in order:

  • Is Ozempic covered for my diagnosis?
  • Does it require prior authorization?
  • Does step therapy apply?
  • Which clinical records are required?
  • Is another GLP-1 preferred for this diagnosis?
  • What quantity and refill limits apply?
  • When would the authorization expire?

What to ask the prescriber and pharmacy

Ask the prescriber whether the authorization included chart notes, labs, diagnosis codes, and treatment history. Confirm when and where it was sent.

Ask the pharmacy for the exact rejection code and message. Confirm the current plan ID, prescribed dose, quantity, National Drug Code, authorization number, and refill date.

What to do if Medicaid denies Ozempic

Get the written denial. Record the appeal deadline.

Next, identify the denial type:

  • Claim error: The pharmacy billed the wrong plan, quantity, code, or fill date.
  • Missing information: The authorization lacks required records.
  • Medical-necessity denial: The plan found that its clinical criteria were not met.
  • Nonpreferred drug: The plan requires another treatment first.
  • Benefit exclusion: The plan does not cover the drug for the requested use.

Do not move straight to cash payment. Check corrections, appeals, and covered alternatives first.

Fix a missing record or pharmacy claim error

Match the rejection to the action. A missing authorization number requires a different response than a refill-too-soon message.

The prescriber can resend chart notes or correct the request. After approval or correction, the pharmacy should rerun the claim using the current plan information.

Request an appeal or state fair hearing

Follow the instructions on the denial notice. Deadlines and appeal steps differ by state and plan.

An appeal may include:

  • The denial notice
  • The prescription
  • Chart notes
  • Lab records
  • Treatment history
  • Prior drug outcomes
  • A prescriber statement

Some programs require a plan appeal before a state fair hearing. Use the sequence shown in the notice rather than relying on a national deadline.

Ask about a covered alternative

Request the preferred-drug list for the same covered diagnosis. Ask the prescriber whether a listed alternative fits the patient’s health needs.

Ozempic, Wegovy, Mounjaro, and Zepbound are not interchangeable for coverage purposes. Each has its own approved uses, doses, and plan criteria.

Does Medicaid cover Wegovy or other weight-loss drugs?

Medicaid weight-loss medication coverage varies by drug, state, plan, and diagnosis. A program may cover diabetes GLP-1 drugs while excluding drugs for chronic weight management.

Some formularies also list non-GLP-1 weight-loss drugs. Verify the exact drug name. Do not ask only whether the plan “covers weight-loss medicine.”

Ozempic vs. Wegovy

Ozempic and Wegovy both contain semaglutide. They have different approved uses, doses, and coverage rules.

Ozempic coverage does not prove Wegovy coverage. A patient denied Ozempic for weight loss can ask whether the plan separately covers Wegovy for chronic weight management.

Mounjaro vs. Zepbound

Mounjaro and Zepbound both contain tirzepatide. They also have different approved uses and plan criteria.

Coverage for Mounjaro does not transfer to Zepbound. The prescription, diagnosis, and authorization must match the requested brand.

When cash-pay care may be an option

Consider cash payment after correcting claim errors, using appeal rights, and reviewing covered alternatives. Cash payment is not Medicaid coverage. It may not count toward plan limits or other benefit calculations.

Temi keeps prescription and GLP-1 care in one place for patients considering an online cash-pay option. Clinical review is still required. We do not promise a prescription, insurance coverage, or a specific result.

FAQ

Can Medicaid cover Ozempic without type 2 diabetes?

It may, but coverage is less likely when Ozempic is prescribed only for weight loss. Ozempic is not FDA-approved as a weight-loss drug, and some plans exclude that use. Check the state and plan table, then ask whether an FDA-approved chronic weight-management drug has separate coverage.

How do I get Ozempic while on Medicaid?

First confirm that Ozempic is covered for the diagnosed condition. Complete any prior authorization and step therapy. Give the prescriber the plan’s records list, then ask the pharmacy to run the claim before pickup. Follow the coverage verification process and save all reference numbers.

How many months does it take to lose 20 pounds on Ozempic?

There is no fixed timeline. Ozempic is not approved as a weight-loss drug, and results vary by dose, diagnosis, starting weight, side effects, adherence, diet, and activity. A prescriber should set realistic review points and decide whether the treatment remains safe and appropriate rather than promising a set monthly loss.

What organ is Ozempic hard on?

No single organ is affected the same way in every patient. Ozempic’s prescribing information contains serious warnings and precautions that require clinical review. Discuss personal risks, health conditions, and other medicines with a prescriber. Seek prompt medical care for severe, persistent, or rapidly worsening symptoms.

Why did Medicaid reject my Ozempic refill?

Common causes include a refill-too-soon rule, quantity limit, expired authorization, dose change, or new health plan. The pharmacy may also have billed the wrong plan information. Ask for the exact rejection code before acting. If needed, use the denial steps to correct or appeal the decision.

Review your GLP-1 care options

Confirm the diagnosis, formulary, prior authorization rule, and claim result first. If Medicaid still will not cover the prescribed treatment, review cash-pay care with Temi and discuss the available options with a licensed prescriber.

Editorial Standards

This article has not been reviewed by a licensed physician. We cite peer-reviewed studies, academic research institutions, and medical associations. Our sources are listed at the end of each article.

If you notice an error or have a concern about our content, please email supportusetemi.com.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

Get started

Start online, and a licensed physician reviews your request

A short online questionnaire is the first step. No appointments and no insurance needed.

A licensed physician reviews every request. Nothing on this page is a prescription.